食品科学 ›› 2021, Vol. 42 ›› Issue (1): 215-221.doi: 10.7506/spkx1002-6630-20191202-020

• 营养卫生 • 上一篇    下一篇

乳酸片球菌AS185调节高脂高糖饮食诱导的代谢综合征

张麟,高磊,王超,赵子健,段翠翠,赵玉娟,杨舸,李盛钰   

  1. (1.吉林省农业科学院农产品加工研究所,吉林 长春 130033;2.吉林农业大学食品科学与工程学院,吉林 长春 130118)
  • 发布日期:2021-01-18
  • 基金资助:
    吉林省农业科技创新工程重大项目(CXGC2017ZD011);现代农业产业技术体系建设专项(CARS-36); 吉林省农业科技创新工程人才基金项目(C92070310)

Pediococcus acidilactici AS185 Improves Metabolic Syndrome Induced by a High-Fat and High-Fructose Diet

ZHANG Lin, GAO Lei, WANG Chao, ZHAO Zijian, DUAN Cuicui, ZHAO Yujuan, YANG Ge, LI Shengyu   

  1. (1. Institute of Agro-food Technology, Jilin Academy of Agricultural Sciences, Changchun 130033, China;2. College of Food Science and Engineering, Jilin Agricultural University, Changchun 130118, China)
  • Published:2021-01-18

摘要: 目的:研究乳酸片球菌(Pediococcus acidilactici)AS185对代谢综合征小鼠的调节作用,并探讨其作用机制。方法:高脂高糖饮食诱导小鼠代谢综合征造模(6 周),灌胃乳酸片球菌AS185,每天1 次,连续8 周,通过测量体质量、血糖浓度、血脂和血清炎症因子水平并进行Western blot检测,评价乳酸片球菌AS185菌株改善代谢综合征的作用和机制。结果:灌胃乳酸片球菌AS185可降低高脂高糖饮食诱导的代谢综合征小鼠血清中总胆固醇、甘油三酯、低密度脂蛋白胆固醇、肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6、胰岛素、空腹血糖、游离脂肪酸、C-反应蛋白和脂多糖水平。Western blot分析结果表明,乳酸片球菌AS185抑制了高脂高糖诱导的核因子κB蛋白的活化、Toll样受体4(Toll-like receptor 4,TLR4)及髓样分化因子(myeloid differentiation factor 88,MyD88)蛋白的表达,抑制炎症通路和炎症因子的表达。乳酸片球菌AS185通过激活肝组织中肝激酶B1(liver kinase B1,LKB1)和腺苷酸活化蛋白激酶(adenylate activated protein kinase,AMPK)的表达,提高磷酸化AMPK和磷酸化乙酰辅酶A羧化酶蛋白表达,并抑制固醇调节元件结合蛋白1c蛋白的表达,调节脂类代谢通路。结论:乳酸片球菌AS185通过激活TLR4-MyD88-NF-κB通路,降低小鼠血清中的炎症因子的水平,并通过激活LKB1-AMPK信号通路,改善代谢综合征小鼠的血脂紊乱,调节高脂高糖饮食导致的代谢综合征。

关键词: 乳酸菌;乳酸片球菌;代谢综合征;胰岛素抵抗;核因子κB;腺苷酸活化蛋白激酶

Abstract: Objective: To study the regulatory effect and underlying mechanism of Pediococcus acidilactici AS185 on metabolic syndrome (MS) in mice. Methods: ICR mice were given a high-fat and high-fructose diet once a day for 6 consecutive weeks to establish an MS model, and AS185 was administered by gavage to the animals once a day from week 7 to 14. The body mass, blood glucose, blood lipid and serum inflammatory factors were determined and Western blot was performed to analyze the expression of relevant proteins. Results: The administration of P. acidilactici AS185 could reduce the serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, insulin (INS), fasting blood glucose (FBG), free fatty acid (FFA), C-reactive protein (CRP) and lipopolysaccharide (LPS) in the mouse model. Western blot analysis showed that P. acidilactici AS185 inhibited the activation of nuclear factor (NF)-κB, and the expression of Toll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88), suppressed inflammatory signaling pathways and the expression of inflammatory factors in the high-fat and high-fructose diet-fed mice. Moreover, it activated liver kinase B1 (LKB1) and the expression of adenylate activated protein kinase (AMPK), thereby enhancing the expression of phosphorylated AMPK (p-AMPK) and phosphorylated acetyl-CoA carboxylase (p-ACC), down-regulating the expression of sterol regulatory element-binding protein-1c (SREBP-1c) and finally regulating the lipid metabolism pathway. Conclusion: P. acidilactici AS185 can improve high-fat and high-fructose diet-induced metabolic syndrome in mice by activating the TLR4-MyD88-NF-κB pathway to regulate inflammatory factor levels, and activating the LKB1-AMPK signaling pathway to improve blood lipid disorders.

Key words: lactic acid bacteria; Pediococcus acidilactici; metabolic syndrome; insulin resistance; nuclear factor kappa-B; adenylate activated protein kinase

中图分类号: